Browse through the entire archive of MasterControl news articles.
Exclusive: MasterControl Software Provides Efficiency, Transparency for Life Science Companies
Contact: Jennifer Hurst, Sr. Director, PR & Content
There are several lessons that companies and investors can learn from the collapse of Theranos and one of the key takeaways is in the area of transparency.
Theranos, which amassed a market value of about $9 billion at one point, was remarkably secretive about its research and, pretty much everything else. If investors were more demanding of transparency, perhaps the troubles the company found itself in, particularly the invalidation of more than 10,000 blood tests that brought on numerous lawsuits and the closure of its laboratories, may not have had to have happened. Calls for greater transparency in the life sciences industry have increased over the years, particularly in the areas of clinical trial research.